Digital Repository

Development and validation of Sinhala version of the chronic liver disease questionnaire (CLDQ)

Show simple item record Miththinda, J.K.N.D. en_US Ranawaka, C. en_US Pathmeswaran, A. en_US Dassanayake, A.S. en_US de Alwis, W.R.S. en_US Mufeena, M.N.F. en_US Senanayake, S.M. en_US Niriella, M.A. en_US de Silva, A.P. en_US de Silva, H.J. en_US 2015-12-24T05:33:33Z en_US 2015-12-24T05:33:33Z en 2013 en_US
dc.identifier.citation Journal of Gastroenterology and Hepatology. 2013; 28(Suppl 3):178 en_US
dc.identifier.issn 0815-9319 (Print) en_US
dc.identifier.issn 1440-1746 (Electronic) en_US
dc.identifier.uri en_US
dc.description Poster Session Abstract (P0407), Gastro 2013 APDW/WCOG Shanghai, Asian Pacific Digestive Week 2013 / World Congress of Gastroenterology, September 21–24, 2013, Shanghai Expo Center, Shanghai, China en_US
dc.description.abstract OBJECTIVE: The Chronic Liver Disease Questionnaire (CLDQ) is a validated tool measuring the Health Related Quality of Life among cirrhotics. Aim of this study was to develop and validate a Sinhala version of the CLDQ (sCLDQ) and to test its correlation with the degree of liver dysfunction in a cohort of Sri Lankan patients with cirrhosis. METHODS: A standard translation method was used to develop the sCLDQ. Pilot testing was done with relevant cultural and language adaptations. The final version was self-administered to stable CLD patients, together with the WHO Quality of Life-BREF (WHOQOL-BREF) validated Sinhala version, for comparison. sCLDQ was re administered 4 weeks later to test internal consistency and reliability. The validation was assessed by Cronabach’s alpha, intraclass correlation coefficient (ICC) and Pearson’s correlation coefficient. ANOVA and Pearson’s correlation were used to test correlation with the degree of liver dysfunction. RESULTS: Validation was done with 214 subjects, mean age 55.6 (SD 10.4) years; male 77.6%. Overall Cronabach’s alpha was 0.926. Itra-class correlations varied from 0.431 to 0.912 and all were significant (p 0.000). Retesting was done on a sub-sample of 18 subjects. Test-retest correlation was 0.695 (p 0.008). WHO-BREF was applied on a sub-sample of 48 subjects. There was a significant correlation (Pearson’s r = 0.391; p = 0.004) between sCLDQ and WHOQOL BREF. sCLDQ was significantly associated with MELD (r = −0.13; p = 0.038), MELD Sodium (r = −0.223; p = 0.002), Bilirubin (r = −0.124; p = 0.036), Serum Sodium (r = 0.172; p = 0.009), Serum Albumin (r = 0.201; p = 0.003) and Child grade (f = 3.687; p = 0.027). CONCLUSION: sCLDQ is a reliable and valid tool to assess QoL of Sri Lankan cirrhotics and correlates well with known indices of disease severity. en_US
dc.language.iso en_US en_US
dc.publisher Wiley Blackwell Scientific Publications en_US
dc.subject Liver Diseases en_US
dc.subject Liver Diseases-diagnosis en_US
dc.subject Validation Studies en_US
dc.subject Surveys and Questionnaires-standards en_US
dc.subject Liver Cirrhosis en_US
dc.title Development and validation of Sinhala version of the chronic liver disease questionnaire (CLDQ) en_US
dc.type Conference Abstract en_US
dc.creator.corporateauthor Asian Pacific Association of Gastroenterology en
dc.creator.corporateauthor Asian Pacific Association for the Study of the Liver en

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference Papers
    Papers presented at local and international conferences by the Staff of the Faculty of Medicine

Show simple item record

Search Digital Repository


My Account